Robert M. Hoffman spends much of his time researching Pathology, Cancer research, Metastasis, Cancer and Green fluorescent protein. He has included themes like Cell culture, Nude mouse, Ratón, Colorectal cancer and Transplantation in his Pathology study. His study in Cancer research is interdisciplinary in nature, drawing from both Salmonella, Tumor progression, Chemotherapy and Immunology.
His Metastasis research integrates issues from Cancer cell, Prostate cancer, Pancreatic cancer and Adenocarcinoma. His Cancer research incorporates themes from Oncology and Lymph node. He interconnects Cytoplasm, Fluorescence-lifetime imaging microscopy, Spleen, Molecular biology and In vivo in the investigation of issues within Green fluorescent protein.
Robert M. Hoffman mostly deals with Cancer research, Cancer, Pathology, Cancer cell and Metastasis. His Cancer research study combines topics from a wide range of disciplines, such as Cell culture, Chemotherapy, Pancreatic cancer, Immunology and Salmonella. In his study, Homocysteine is inextricably linked to Methionine, which falls within the broad field of Cancer.
The concepts of his Pathology study are interwoven with issues in Angiogenesis, Green fluorescent protein, Nude mouse, Colorectal cancer and Transplantation. His research in Green fluorescent protein tackles topics such as In vivo which are related to areas like In vitro. His Cancer cell research is multidisciplinary, incorporating elements of Cell, Cell cycle, Apoptosis, Stromal cell and Cell biology.
His main research concerns Cancer research, Cancer, Cancer cell, Metastasis and Nude mouse. His Cancer research research is multidisciplinary, incorporating perspectives in Recombinant DNA, Chemotherapy, Doxorubicin, Pancreatic cancer and In vivo. Robert M. Hoffman combines subjects such as Cell culture and In vitro with his study of In vivo.
As a part of the same scientific family, Robert M. Hoffman mostly works in the field of Cancer, focusing on Combination therapy and, on occasion, Fluorouracil. His Cancer cell research incorporates elements of Cell cycle and Lung cancer. His Metastasis research is multidisciplinary, relying on both Stromal cell, Pathology and Green fluorescent protein.
Robert M. Hoffman focuses on Cancer research, Cancer, Doxorubicin, Nude mouse and Recombinant DNA. His work deals with themes such as Cancer cell, Metastasis and Pancreatic cancer, which intersect with Cancer research. His studies in Metastasis integrate themes in fields like Integrin, Salmonella and Adenocarcinoma.
His study ties his expertise on Combination therapy together with the subject of Cancer. His study focuses on the intersection of Nude mouse and fields such as Gemcitabine with connections in the field of Docetaxel. His Recombinant DNA study combines topics from a wide range of disciplines, such as Tumor size, Soft tissue sarcoma, Tumor targeting, Pharmacology and Methionine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.
Clemens A. Schmitt;Jordan S. Fridman;Meng Yang;Soyoung Lee.
Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force
Katarina Wolf;Mariska te Lindert;Marina Krause;Stephanie Alexander.
Journal of Cell Biology (2013)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi;Hannes Vogel;Geoffrey Schultz;Robert M. Hoffman.
Journal of Clinical Investigation (2010)
The multiple uses of fluorescent proteins to visualize cancer in vivo
Robert M. Hoffman.
Nature Reviews Cancer (2005)
Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases
Meng Yang;Eugene Baranov;Ping Jiang;Fang-Xian Sun.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.
Robert M. Hoffman.
Investigational New Drugs (1999)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling
Wei Tan;Weizhou Zhang;Amy Strasner;Sergei Grivennikov.
Dissecting p53 tumor suppressor functions in vivo
Clemens A Schmitt;Jordan S Fridman;Meng Yang;Eugene Baranov.
Cancer Cell (2002)
Gene expression profiling predicts clinical outcome of prostate cancer.
Gennadi V. Glinsky;Anna B. Glinskii;Andrew James Stephenson;Robert M. Hoffman.
Journal of Clinical Investigation (2004)
Biomimetic amplification of nanoparticle homing to tumors
Dmitri Simberg;Tasmia Duza;Ji Ho Park;Markus Essler.
Proceedings of the National Academy of Sciences of the United States of America (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: